Literature DB >> 24339739

Cyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics.

Atsushi Fujimura1, Hiroyuki Michiue, Yan Cheng, Atsuhito Uneda, Yasunari Tani, Tei-ichi Nishiki, Tomotsugu Ichikawa, Fan-Yan Wei, Kazuhito Tomizawa, Hideki Matsui.   

Abstract

Microenvironmental conditions such as hypoxia potentiate the local invasion of malignant tumors including glioblastomas by modulating signal transduction and protein modification, yet the mechanism by which hypoxia controls cytoskeletal dynamics to promote the local invasion is not well defined. Here, we show that cyclin G2 plays pivotal roles in the cytoskeletal dynamics in hypoxia-driven invasion by glioblastoma cells. Cyclin G2 is a hypoxia-induced and cytoskeleton-associated protein and is required for glioblastoma expansion. Mechanistically, cyclin G2 recruits cortactin to the juxtamembrane through its SH3 domain-binding motif and consequently promotes the restricted tyrosine phosphorylation of cortactin in concert with src. Moreover, cyclin G2 interacts with filamentous actin to facilitate the formation of membrane ruffles. In primary glioblastoma, cyclin G2 is abundantly expressed in severely hypoxic regions such as pseudopalisades, which consist of actively migrating glioma cells. Furthermore, we show the effectiveness of dasatinib against hypoxia-driven, cyclin G2-involved invasion in vitro and in vivo. Our findings elucidate the mechanism of cytoskeletal regulation by which severe hypoxia promotes the local invasion and may provide a therapeutic target in glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24339739      PMCID: PMC3858900          DOI: 10.1593/neo.131440

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  38 in total

1.  Mechanism of actin network attachment to moving membranes: barbed end capture by N-WASP WH2 domains.

Authors:  Carl Co; Derek T Wong; Sarah Gierke; Vicky Chang; Jack Taunton
Journal:  Cell       Date:  2007-03-09       Impact factor: 41.582

Review 2.  Malignant gliomas in adults.

Authors:  Patrick Y Wen; Santosh Kesari
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

3.  Src-mediated cortactin phosphorylation regulates actin localization and injurious blebbing in acinar cells.

Authors:  Vijay P Singh; Mark A McNiven
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

4.  Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.

Authors:  Guoxiong Xu; Stefanie Bernaudo; Guodong Fu; Daniel Y Lee; Burton B Yang; Chun Peng
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

5.  Distinct phospho-forms of cortactin differentially regulate actin polymerization and focal adhesions.

Authors:  Anne E Kruchten; Eugene W Krueger; Yu Wang; Mark A McNiven
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-03       Impact factor: 4.249

6.  A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.

Authors:  Maddalena Adorno; Michelangelo Cordenonsi; Marco Montagner; Sirio Dupont; Christine Wong; Byron Hann; Aldo Solari; Sara Bobisse; Maria Beatrice Rondina; Vincenza Guzzardo; Anna R Parenti; Antonio Rosato; Silvio Bicciato; Allan Balmain; Stefano Piccolo
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

7.  Development of a novel mouse glioma model using lentiviral vectors.

Authors:  Tomotoshi Marumoto; Ayumu Tashiro; Dinorah Friedmann-Morvinski; Miriam Scadeng; Yasushi Soda; Fred H Gage; Inder M Verma
Journal:  Nat Med       Date:  2009-01-04       Impact factor: 53.440

8.  Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.

Authors:  Marta Pàez-Ribes; Elizabeth Allen; James Hudock; Takaaki Takeda; Hiroaki Okuyama; Francesc Viñals; Masahiro Inoue; Gabriele Bergers; Douglas Hanahan; Oriol Casanovas
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

9.  Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis.

Authors:  Brian T Ragel; William T Couldwell; David L Gillespie; Randy L Jensen
Journal:  Neurosurg Rev       Date:  2007-05-08       Impact factor: 2.800

10.  Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.

Authors:  Jinyan Du; Paula Bernasconi; Karl R Clauser; D R Mani; Stephen P Finn; Rameen Beroukhim; Melissa Burns; Bina Julian; Xiao P Peng; Haley Hieronymus; Rebecca L Maglathlin; Timothy A Lewis; Linda M Liau; Phioanh Nghiemphu; Ingo K Mellinghoff; David N Louis; Massimo Loda; Steven A Carr; Andrew L Kung; Todd R Golub
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

View more
  14 in total

1.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

2.  [MACF1 knockdown in glioblastoma multiforme cells increases temozolomide-induced cytotoxicity].

Authors:  Si-di Xie; Zi-Yang Chen; Hai Wang; Min-Yi He; Yun-Tao Lu; Bing-Xi Lei; He-Zhen Li; Ya-Wei Liu; Song-Tao Qi
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

3.  Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.

Authors:  Y Otani; T Ichikawa; K Kurozumi; S Inoue; J Ishida; T Oka; T Shimizu; Y Tomita; Y Hattori; A Uneda; Y Matsumoto; H Michiue; I Date
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

4.  Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma.

Authors:  Deanna M Tiek; Subreen A Khatib; Colin J Trepicchio; Mary M Heckler; Shailaja D Divekar; Jann N Sarkaria; Eric Glasgow; Rebecca B Riggins
Journal:  FASEB J       Date:  2019-09-28       Impact factor: 5.834

5.  Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.

Authors:  Cheng-Shi Xu; Ze-Fen Wang; Xiao-Dong Huang; Li-Ming Dai; Chang-Jun Cao; Zhi-Qiang Li
Journal:  J Transl Med       Date:  2015-03-20       Impact factor: 5.531

6.  The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma.

Authors:  Luigi Sforna; Marta Cenciarini; Silvia Belia; Maria Cristina D'Adamo; Mauro Pessia; Fabio Franciolini; Luigi Catacuzzeno
Journal:  Front Cell Neurosci       Date:  2015-01-15       Impact factor: 5.505

Review 7.  The Role of Hypoxia in Glioblastoma Invasion.

Authors:  Ana Rita Monteiro; Richard Hill; Geoffrey J Pilkington; Patrícia A Madureira
Journal:  Cells       Date:  2017-11-22       Impact factor: 6.600

8.  Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma.

Authors:  Chenggong Hu; Yongfang Zhou; Chang Liu; Yan Kang
Journal:  Oncol Rep       Date:  2018-08-10       Impact factor: 3.906

9.  2-Methylthio Conversion of N6-Isopentenyladenosine in Mitochondrial tRNAs by CDK5RAP1 Promotes the Maintenance of Glioma-Initiating Cells.

Authors:  Takahiro Yamamoto; Atsushi Fujimura; Fan-Yan Wei; Naoki Shinojima; Jun-Ichiro Kuroda; Akitake Mukasa; Kazuhito Tomizawa
Journal:  iScience       Date:  2019-10-08

10.  In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy.

Authors:  Atsushi Fujimura; Seiji Yasui; Kazuyo Igawa; Ai Ueda; Kaori Watanabe; Tadashi Hanafusa; Yasuaki Ichikawa; Sachiko Yoshihashi; Kazuki Tsuchida; Atsunori Kamiya; Shuichi Furuya
Journal:  Cells       Date:  2020-09-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.